| |
| | BioMed Central | Full text | The relation between deoxycytidine kinase activity and the radiosensitising effect of ... |
 | | In the present study, the relation between deoxycytidine kinase (dCK) activity and the radiosensitising effect of gemcitabine was investigated in eight different human tumour cell lines. |
 | | Gemcitabine (2',2'-difluorodeoxycytidine, dFdC) is a synthetic pyrimidine nucleoside analogue that has a structure very similar to that of deoxycytidine and cytosine arabinoside (Ara-C) In clinical use, gemcitabine is active against a variety of solid tumours such as cancers of the pancreas, lung, head and neck, bladder, breast, and ovary. |
 | | Stegmann AP, Honders MW, Hagemeijer A, Hoebee B, Willemze R, Landegent JE: In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2'-deoxycytidine (DAC) in a rat modelfor acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase (dck) gene. |
| www.biomedcentral.com /1471-2407/6/142 (5061 words) |
|